Search results for "severity"

showing 10 items of 1287 documents

Efficacy of switching between tumor necrosis factor-alfa inhibitors in psoriasis: results from the Italian Psocare registry

2014

Background: Some studies have shown that switching patients from one tumor necrosis factor (TNF)-alfa inhibitor to another may be beneficial when they have an inadequate response or an adverse event. Objective: We sought to assess the variables predicting the efficacy of the second TNF-alfa inhibitor in patients discontinuing the first TNF-alfa inhibitor. Methods: Data from all 5423 consecutive patients starting TNF-alfa inhibitor therapy for psoriasis between September 2005 and September 2010 who were included in the Italian Psocare registry were analyzed. Results: In 105 patients who switched to a second TNF-alfa inhibitor who had complete follow-up data, 75% improvement in the Psoriasis …

Maleprimary inefficacy75% improvement in the Psoriasis Area Severity Index score; PASI; PASI 75; Psoriasis Area Severity Index; TNF; biologics; efficacy; primary inefficacy; psoriasis; secondary loss of efficacy; switching; tumor necrosis factor; tumor necrosis factor-alfa inhibitors; Adult; Analysis of Variance; Antibodies Monoclonal; Antibodies Monoclonal Humanized; Cohort Studies; Confidence Intervals; Dose-Response Relationship Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Immunoglobulin G; Italy; Male; Middle Aged; Multivariate Analysis; Predictive Value of Tests; Proportional Hazards Models; Psoriasis; Receptors Tumor Necrosis Factor; Registries; Retrospective Studies; Risk Assessment; Severity of Illness Index; Treatment Outcome; Tumor Necrosis Factor-alpha; Young AdultSWITHCESefficacyTNFpsoriasis; psoriasis arthritis; pharmachological treatmentPASI 75Severity of Illness IndexReceptors Tumor Necrosis FactorEtanerceptCohort StudiesMonoclonalReceptorsSettore MED/35 - Malattie Cutanee E VenereeRegistriesHumanizedtumor necrosis factor-alfa inhibitors.switchingHazard ratioAntibodies MonoclonalMiddle AgedTreatment OutcomeItalyPredictive value of tests75% improvement in the Psoriasis Area Severity Index scoreFemaleDrugPsoriasis Area Severity IndexbiologicTNF-alphaAdultmedicine.medical_specialtytumor necrosis factorDermatology75% improvement in the Psoriasis Area Severity Index score; PASI; PASI 75; Psoriasis Area Severity Index; TNF; biologics; efficacy; primary inefficacy; psoriasis; secondary loss of efficacy; switching; tumor necrosis factor; tumor necrosis factor-alfa inhibitorsAntibodies Monoclonal Humanizedsecondary loss of efficacyRisk AssessmentAntibodiestumor necrosis factor-alfa inhibitorsDrug Administration ScheduleDose-Response RelationshipYoung AdultSettore MED/35Predictive Value of TestsInternal medicinePsoriasisSeverity of illnessmedicineConfidence IntervalsHumansPsoriasisbiologicsAdverse effectPsoriasis; TNF-alphaProportional Hazards ModelsRetrospective Studiespsoriasibiologics; efficacy; primary inefficacy; psoriasis; secondary loss of efficacy; switching; tumor necrosis factor-alfa inhibitors; Adalimumab; Adult; Analysis of Variance; Antibodies Monoclonal; Antibodies Monoclonal Humanized; Cohort Studies; Confidence Intervals; Dose-Response Relationship Drug; Drug Administration Schedule; Etanercept; Female; Follow-Up Studies; Humans; Immunoglobulin G; Infliximab; Italy; Male; Middle Aged; Multivariate Analysis; Predictive Value of Tests; Proportional Hazards Models; Psoriasis; Receptors Tumor Necrosis Factor; Registries; Retrospective Studies; Risk Assessment; Severity of Illness Index; Treatment Outcome; Tumor Necrosis Factor-alpha; Young Adult; 2708Analysis of Variancepharmachological treatmentDose-Response Relationship DrugProportional hazards modelbusiness.industrytumor necrosis factor-alfa inhibitorTumor Necrosis Factor-alphaPASIAdalimumabRetrospective cohort studypsoriasis arthritismedicine.diseaseConfidence intervalInfliximabSurgeryImmunoglobulin GMultivariate AnalysisANTI-TNFAbusiness2708Follow-Up Studies
researchProduct

Drug‐refractory myasthenia gravis: Clinical characteristics, treatments, and outcome

2022

[Objective] To describe the clinical characteristics and outcomes in patients with refractory myasthenia gravis (MG) and to determine the effectiveness and side effects of the drugs used for their treatment.

Maleprogressive multifocal leukoencepdiarrheacholinergic receptorplasma exchangemiddle agedadultimmunologic factornauseaanemiahypertrichosisageddrug withdrawaldiabetes mellitusdisease severityTRIALsafetycorticosteroidhypertensionImmunologyMiastenia gravismethotrexateArticlebulbar paralysispancytopeniaMuscular DiseasescompulsionMyasthenia Gravischolinesterase inhibitorcross-sectional studyHumansImmunologic FactorshumanRITUXIMABarthralgiaNeurologíaMalalties muscularsAgedRetrospective Studiesmyasthenia gravisleukopeniaabdominal painDrug testingmajor clinical studyCross-Sectional StudiesDrug side effectscyclophosphamideobservational studyNeurology (clinical)immunoglobulinFEATURESefficacyclinical outcomeelectrophysiological procedurescomputer assisted tomographyDOUBLE-BLINDTratamiento médicorituximabOutcome Assessment Health CareImmunologiamuscle specific tyrosine kinaseRegistriestacrolimusazathioprineMedicamentoGeneral Neurosciencenephrotoxicitygeneral condition deteriorationhyperplasiatrialMiddle Agedliver toxicitydrug toxicityunclassified drugfemaleEfectes secundaris dels medicamentsSAFETYFemaledouble-blindheadacheblindnessAdultAssaigs clínics de medicamentsmalefeaturesfollow uppneumoniacyclosporinemycophenolate mofetilprotein tyrosine kinaseimmunosuppressive agentallergyalopeciaEFFICACYclinical featureosteopeniaSpainprednisonehyperglycemiaautoantibodyFollow-Up Studies
researchProduct

Validation of the Western Ontario and McMaster Universities Osteoarthritis Index in Patients Having Undergone Ankle Fracture Surgery

2019

The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) is a patient-reported outcome measure (PROM) that is widely used to evaluate the pain, stiffness, and physical function of patients with osteoarthritis of the hip and knee. Although the WOMAC has also been used for patients after foot and ankle surgery, it has not been validated for this purpose. A total of 130 patients with surgically treated ankle fractures completed the WOMAC, Visual Analogue Scale Foot and Ankle (VAS FA), Lower Extremity Functional Scale (LEFS), 15D Health-Related Quality-of-Life Questionnaire (15D), and Visual Analog Scale for General Health (VAS general health) after foot and ankle surgery. The…

MalepsychometricsVisual Analog Scalemedicine.medical_treatmentOsteoarthritisFINNISH VERSIONSeverity of Illness Index0302 clinical medicineFracture FixationQUALITY-OF-LIFESurveys and QuestionnairesFracture fixationOrthopedics and Sports MedicineProspective Studies030212 general & internal medicineOntarioPain PostoperativeINSTRUMENTMiddle Aged3. Good healthmedicine.anatomical_structureWOMACConvergent validityRELIABILITYFemaleVAS-FACOEFFICIENTmusculoskeletal diseasesmedicine.medical_specialtyWOMACUniversitiesVisual analogue scalereliability validityAnkle FracturesANALOG SCALE FOOT03 medical and health sciencesOsteoarthritisanklemedicineHumansPatient Reported Outcome MeasuresVALIDITYARTHROPLASTYRASCH ANALYSIS030203 arthritis & rheumatologybusiness.industryFoot and ankle surgeryReproducibility of Results3126 Surgery anesthesiology intensive care radiologymedicine.diseaseArthroplastySurgeryQuality of LifePhysical therapySurgeryLEFSAnklebusinessFollow-Up StudiesThe Journal of Foot and Ankle Surgery
researchProduct

Impact of tiotropium + olodaterol on physical functioning in COPD: results of an open-label observational study

2016

Rüdiger Sauer,1 Michaela Hänsel,2 Roland Buhl,3 Roman A Rubin,4 Marcel Frey,5 Thomas Glaab2,3 1Lung Centre Ulm, Ulm, Germany; 2Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany; 3Pulmonary Department, Mainz University Hospital, Mainz, Germany; 4Pulmonary Specialist Practice, Wiesbaden, Germany; 5Biometrics, Alcedis GmbH, Gießen, Germany Background: Maintaining and improving physical functioning is key to mitigating the cycle of deconditioning associated with chronic obstructive pulmonary disease (COPD). We evaluated the impact of free combination of the long-acting anticholinergic tiotropium plus the long-acting β2-agonist ol…

Malereal-worldTime FactorsnoninterventionalHealth StatusSeverity of Illness IndexCholinergic AntagonistsPulmonary Disease Chronic Obstructivechemistry.chemical_compound0302 clinical medicinetiotropiumDeconditioningPhysical functioningSurveys and QuestionnairesProspective Studies030212 general & internal medicineLungOriginal ResearchCOPDOlodaterolGeneral MedicineTiotropium bromideMiddle AgedBronchodilator AgentsDrug CombinationsTreatment OutcomeFemalemedicine.drugmedicine.medical_specialtymedicine.drug_classInternational Journal of Chronic Obstructive Pulmonary Diseasechronic obstructive pulmonary disease03 medical and health sciencesAdministration InhalationSeverity of illnessmedicineAnticholinergicphysical functioningHumansTiotropium BromideIntensive care medicineAdrenergic beta-2 Receptor AgonistsAgedolodaterolbusiness.industryNebulizers and VaporizersRecovery of Functionmedicine.diseaseBenzoxazines030228 respiratory systemchemistryPhysical therapyObservational studybusinessInternational Journal of Chronic Obstructive Pulmonary Disease
researchProduct

The profiles of health care utilization among a non-depressed population and patients with depressive symptoms with and without clinical depression

2019

Objective: To examine health service (HS) utilization profiles among a non-depressive population and patients with depressive symptoms (DS) with and without clinical depression. Design, subjects and setting: The study population was based on primary care patients with DS scoring ≥10 in the 21-item Beck Depression Inventory (BDI) and who were at least 35 years old and had been referred to depression nurse case managers (n = 705). Their psychiatric diagnosis was confirmed with the Mini-International Neuropsychiatric Interview (M.I.N.I.). Of these patients, 447 had clinical depression. The number of patients with DS without clinical depression was 258. The control group consisted of a random s…

MaleterveyspalvelutPrimary health careNursesINVENTORYkäyttöSeverity of Illness IndexHealth services0302 clinical medicinedepressive symptomsHealth careSERVICE UTILIZATION030212 general & internal medicineDepression (differential diagnoses)Primary health careRISKeducation.field_of_studylcsh:Public aspects of medicine030503 health policy & servicespublic healthMiddle Aged3142 Public health care science environmental and occupational health3. Good healthPREVALENCEdepressionFemale0305 other medical scienceResearch ArticlemasennusAdultmedicine.medical_specialtyDISORDERSPopulation03 medical and health sciencesGeneral PractitionersService utilizationmedicineHumanseducationPsychiatryhealth servicesDepressive symptomsperusterveydenhuoltoPsychiatric Status Rating ScalesDepressive Disorderbusiness.industryPublic healthPublic Health Environmental and Occupational Healthlcsh:RA1-1270MAJOR DEPRESSIONPatient Acceptance of Health Careprimary health careLIFEbusiness
researchProduct

Urinary tract infections in children: EAU/ESPU guidelines.

2015

Context: In 30% of children with urinary tract anomalies, urinary tract infection (UTI) can be the first sign. Failure to identify patients at risk can result in damage to the upper urinary tract.Objective: To provide recommendations for the diagnosis, treatment, and imaging of children presenting with UTI.Evidence acquisition: The recommendations were developed after a review of the literature and a search of PubMed and Embase. A consensus decision was adopted when evidence was low.Evidence synthesis: UTIs are classified according to site, episode, symptoms, and complicating factors. For acute treatment, site and severity are the most important. Urine sampling by suprapubic aspiration or c…

Maleurologic and male genital diseasesPediatricsSeverity of Illness IndexESPUVOIDING CYSTOURETHROGRAPHYFollow-up imagingSuprapubic aspirationRisk FactorsDiagnosisguidelinesAntibiotic prophylaxisChildChildrenObstructive uropathyUpper urinary tractUrinary tract infectionDiagnostic Techniques Urologicalfemale genital diseases and pregnancy complicationsAnti-Bacterial AgentsTreatment OutcomeEAUAntibacterial treatmentUrinary Tract InfectionsFemalePRIMARY VESICOURETERAL REFLUXmedicine.symptomYOUNG-CHILDRENmedicine.medical_specialtyUrologyRenal scarUrologyBacteriuriaCONTROLLED-TRIALSUPRAPUBIC ASPIRATIONVesicoureteral reflux1ST FEBRILE UTIANTIBIOTIC-PROPHYLAXISPredictive Value of TestsUrine samplingInternal medicineUltrasoundmedicineHumansTRANSABDOMINAL ULTRASOUNDACUTE PYELONEPHRITISbusiness.industryInfant NewbornInfantmedicine.diseasePyuriaTreatmentLeukocyte esteraseFOLLOW-UPbusinessEuropean urology
researchProduct

Autogenous calvarium bone grafting as a treatment for severe bone resorption in the upper maxilla : a case report

2008

Atrophic maxilla rehabilitation has been the subject of several studies for decades; despite this, there are still many different therapeutic choices for the best way to treat maxillary resorption in order to enable implant placement and integration. These possibilities include the optimal use of remaining bone structures, such as the pterygoid processes or zygomatic arch, which involves using zygomaticus and pterygoid implants in combination with standard implants placed in the residual bone; alternatively, regenerative techniques, alveolar bone expansion/distraction or bone grafting techniques may be used. Severe maxillary atrophy has a multifactorial aetiology; the most important factors…

Maxillary sinusmedicine.medical_treatmentDentistryBone graftingSeverity of Illness IndexBone resorptionAtrophymedicineHumansBone ResorptionGeneral DentistryEdentulismbusiness.industrySkullMiddle Agedmedicine.disease:CIENCIAS MÉDICAS [UNESCO]Maxillary DiseasesResorptionmedicine.anatomical_structureOtorhinolaryngologyMaxillaUNESCO::CIENCIAS MÉDICASSurgeryZygomatic archFemalebusiness
researchProduct

Anxiety and the severity of Tension-Type Headache mediate the relation between headache presenteeism and workers’ productivity

2018

The primary objective of this study was to explore the mechanisms and conditions whereby Tension-Type Headache (TTH) presenteeism relates to health-related loss of productivity as a result of both reduced physical and mental health. To this end, Structural Equation Modeling (SEM) was used to conduct a secondary data analysis of a randomized clinical trial involving 78 Tension-type Headache (TTH) patients. The results showed that TTH presenteeism did not directly relate to health-related loss of productivity, either due to physical, or mental health problems. However, through anxiety-state, TTH presenteeism decreased patients' productivity, as consequence of reduced physical and mental healt…

Medical DoctorsHealth Care ProvidersEmotionslcsh:MedicineSocial SciencesAnxietyPathology and Laboratory Medicinelaw.invention0302 clinical medicineRandomized controlled trialSociologylawMedicine and Health SciencesPsychologyPublic and Occupational HealthMedical Personnellcsh:ScienceMultidisciplinaryHeadaches05 social sciencesProfessionsSocial SystemsAnxietyHeadachesmedicine.symptomBehavioral and Social Aspects of HealthClinical psychologyResearch Article03 medical and health sciencesSigns and SymptomsDiagnostic MedicinePhysicians0502 economics and businessSeverity of illnessMental Health and PsychiatrymedicineMigrainebusiness.industrylcsh:RTension-Type HeadacheBiology and Life SciencesSecondary datamedicine.diseaseMental healthHealth CareMigrainePresenteeismPeople and Placeslcsh:QPopulation Groupingsbusiness050203 business & management030217 neurology & neurosurgeryPLoS ONE
researchProduct

Predicting patient post-detoxification engagement in 12-step groups with an extended version of the theory of planned behavior

2015

Introduction Individuals with substance use disorders can receive important abstinence-specific support in 12-step groups (TSGs). However, our understanding of key factors that influence TSG participation remains limited. This study used an extended version of the theory of planned behavior (TPB) to enhance the understanding of TSG affiliation. Methods Data were retrieved from a controlled trial of a 12-step facilitation intervention conducted on an inpatient detoxification ward in Norway (N = 140). Surveys at baseline included a TPB questionnaire. The behavioral target was to attend at least two TSG meetings per month in the 6-month follow-up period. Structural equation modeling was used t…

Medicine(all)AdultMaleHealth Knowledge Attitudes PracticeMotivationNorwaySubstance-Related DisordersResearchIntentionMiddle AgedModels PsychologicalSeverity of Illness IndexTheory of planned behaviorSelf-Help GroupsDetoxification treatmentSocioeconomic FactorsHumansFemaleAlcohol-Related DisordersAlcoholics Anonymous
researchProduct

The Role of Nutritional Lifestyle and Physical Activity in Multiple Sclerosis Pathogenesis and Management: A Narrative Review

2021

Studies on the role of nutritional factors and physical activity (PA) in the pathogenesis of multiple sclerosis (MS) go back a long time. Despite the intrinsic difficulty of studying their positive or negative role in MS, the interest of researchers on these topics increased during the last few decades, since the role of diet has been investigated with the perspective of the association with disease-modifying drugs (DMD). The association of DMD, diets, and PA might have an additive effect in modifying disease severity. Among the various diets investigated (low-carbohydrate, gluten-free, Mediterranean, low-fat, fasting-mimicking, and Western diets) only low-carbohydrate, Mediterranean, and f…

Mediterranean dietlow carbohydrate dietPhysical activityPhysiologyphysical activityReviewlow-fat dietmultiple sclerosisDisease coursePathogenesisDisease severitygluten-free dietMediterranean dietWestern dietmedicineAnimalsHumansNutritional Physiological PhenomenaTX341-641Western dietExerciseLife StyleNutrition and Dieteticsbusiness.industryNutrition. Foods and food supplyMultiple sclerosisPatient Acuitymedicine.diseasefasting-mimicking dietNarrative reviewSettore MED/26 - NeurologiaDiet HealthybusinessFood Sciencenutritional lifestyles
researchProduct